WOBURN, Mass., Feb. 13, 2024 /PRNewswire/ — Intrinsic Therapeutics, Inc., the developer of the Barricaid, an FDA approved medical device proven to significantly reduce reherniations and reoperations following lumbar discectomy surgery, today announced the appointment of Dave Amerson and…